However, the vast majority (10 out of 11) of the female Hjv−/− mice manifested HCC within 24 weeks of DEN treatment, demonstrating increased sensitivity of this mouse model to hepatocarcinogenesis. The gene discussed is HJV; the disease is hepatocellular carcinoma.